Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float
Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...
940 Views
Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet
Anthem Biosciences is looking to raise up to US$400m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
384 Views
RPG Life Sciences (NOT RATED): Annual investor conference takeaways
RPGL reported revenue growth, margin expansion and debt reduction in FY21 despite Covid-led disruptions in the acute portfolio
210 Views
RPG Lifescience - A Turnaround Story
We believe that Rpg Life Sciences Ltd (RPGL IN) is at an inflection point with new products driving growth – both in Indian market (64%...
181 Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
5k Views